Tygh Capital Management Inc. raised its position in shares of Teladoc Health Inc (NYSE:TDOC) by 9.9% in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 106,442 shares of the health services provider’s stock after buying an additional 9,553 shares during the period. Tygh Capital Management Inc. owned about 0.15% of Teladoc Health worth $7,069,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Legal & General Group Plc lifted its holdings in Teladoc Health by 6.2% in the fourth quarter. Legal & General Group Plc now owns 26,209 shares of the health services provider’s stock valued at $1,299,000 after buying an additional 1,540 shares during the period. Dimensional Fund Advisors LP increased its stake in Teladoc Health by 95.8% in the fourth quarter. Dimensional Fund Advisors LP now owns 207,443 shares of the health services provider’s stock valued at $10,282,000 after purchasing an additional 101,498 shares in the last quarter. Geode Capital Management LLC increased its stake in Teladoc Health by 10.3% in the fourth quarter. Geode Capital Management LLC now owns 729,201 shares of the health services provider’s stock valued at $36,146,000 after purchasing an additional 68,049 shares in the last quarter. Virtu Financial LLC bought a new stake in Teladoc Health in the first quarter valued at $334,000. Finally, Flagship Harbor Advisors LLC increased its stake in Teladoc Health by 87.8% in the first quarter. Flagship Harbor Advisors LLC now owns 616 shares of the health services provider’s stock valued at $34,000 after purchasing an additional 288 shares in the last quarter.

TDOC stock traded up $0.95 during trading on Wednesday, reaching $61.23. The stock had a trading volume of 12,902 shares, compared to its average volume of 1,460,091. Teladoc Health Inc has a one year low of $42.08 and a one year high of $89.05. The company has a quick ratio of 7.56, a current ratio of 7.56 and a debt-to-equity ratio of 0.43. The company’s 50 day moving average is $67.34 and its two-hundred day moving average is $62.04. The company has a market capitalization of $4.38 billion, a price-to-earnings ratio of -42.49 and a beta of 1.30.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings data on Wednesday, July 31st. The health services provider reported ($0.41) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.40) by ($0.01). Teladoc Health had a negative return on equity of 10.64% and a negative net margin of 21.85%. The firm had revenue of $130.30 million during the quarter, compared to the consensus estimate of $129.54 million. During the same period in the previous year, the company posted ($0.40) earnings per share. The company’s revenue for the quarter was up 37.8% on a year-over-year basis. As a group, research analysts predict that Teladoc Health Inc will post -1.56 earnings per share for the current fiscal year.

Several equities research analysts have weighed in on TDOC shares. SunTrust Banks lifted their price target on shares of Teladoc Health to $80.00 and gave the company a “positive” rating in a research note on Tuesday, August 6th. Zacks Investment Research raised shares of Teladoc Health from a “sell” rating to a “hold” rating in a research note on Friday, May 3rd. Svb Leerink reaffirmed an “outperform” rating on shares of Teladoc Health in a research note on Thursday, August 1st. Jefferies Financial Group reissued a “buy” rating and set a $95.00 target price on shares of Teladoc Health in a research report on Tuesday, July 2nd. Finally, Craig Hallum boosted their target price on shares of Teladoc Health from $70.00 to $80.00 and gave the stock a “buy” rating in a research report on Thursday, August 1st. Three equities research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has issued a strong buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average price target of $83.28.

In other Teladoc Health news, SVP Andrew Turitz sold 9,157 shares of the business’s stock in a transaction dated Monday, June 17th. The shares were sold at an average price of $60.05, for a total value of $549,877.85. Following the transaction, the senior vice president now directly owns 6,826 shares in the company, valued at $409,901.30. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, President Peter A. Mcclennen sold 13,753 shares of the business’s stock in a transaction dated Monday, July 15th. The shares were sold at an average price of $70.99, for a total transaction of $976,325.47. Following the completion of the transaction, the president now owns 29,412 shares in the company, valued at $2,087,957.88. The disclosure for this sale can be found here. Over the last quarter, insiders sold 131,763 shares of company stock worth $8,757,848. Corporate insiders own 3.14% of the company’s stock.

About Teladoc Health

Teladoc Health, Inc provides telehealth services. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.

Recommended Story: The components of the Stochastic Momentum Index

Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Health Inc (NYSE:TDOC).

Institutional Ownership by Quarter for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.